1[1]Rosamond W,Flegal K,Friday G,et al.Heart disease and stroke statistics-2007 update:a report from the American Heart Association Statistics Committee and Stroke Statistics subcommittee[J].Circulation,2007,115(5):e69-e71.
2[2]Leal J,Luengo Fernández R,Gray A,et al.Economic burden of cardiovascular diseases in the enlarged European Union[J].Eur Heart J,2006,27(13):1610-1619.
3[3]Poole-Wilson PA,Voko Z,Kirwan BA,et al.Clinical course of isolated stable angina due to coronary heart disease[J].Eur Heart J,2007,28(16):1928-1935.
4[4]Fox K,Garcia MA,Ardissino D,et al.Guidelines on the management of stable angina pectoris:executive summary:The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology[J].Eur Heart J,2006,27(11):1341-1381.
6[6]Bax JJ,Bonow RO,Tschope D,et al.The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes[J].J Am CollCardiol,2006,48(4):754-760.
7[7]Meijboom WB,van Mieghem CA,Mollet NR,et al.64-slidce computed tomography coronary angiography in patients with high，intermediate,or low pretest probability of significant coronary artery disease[J].J Am Coll Cardiol,2007,50(15):1469-1475.
8[8]Gibbons RJ,Abrams J,Chatterjee K,et al.ACC/AHA2002 guideline update for the management of patients with chronic stable angina--summary article:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines(Committee on the Management of Patients With Chronic Stable Angina)[J].J Am Coll Cardiol,2003,41(1):159-168.
9[9]Fox KM.EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:randomized,double-blind,placebo-controlled,multicenter trial(the EUROPA study)[J].Lancet,2003.362(9386):782-788.
10[10]Brugts JJ,Boersma E,Chonchol M,et al.The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency:Insights from the EUROPA trial[J].J Am CollCardiol,2007,50(22):2148-2155.
二级参考文献48
1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.
9Faggiano P,Aloia AD,Gualeni A,et al.Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure:Preliminary experience with a portable device[J].Am Heart J,1997,287(12):203-206.
10Bittner V,Winer DH,Yusuf S,et al.Prediction of mortality and morbidity with a 6-minute walking test in patients with left ventricular dysfunction:SOLVD Investgators[J].JAMA,1993,270(14):1702-1707.
